Cancel
See Linkedin
Known information
- Holds a Ph.D. in Biostatistics.
- Experienced statistician, modeler, engineer, and mathematical scientist.
- Focused on realizing the promise of precision medicine and translating research achievements to viable commercial products in a highly regulated environment.
- Held leadership roles in biostatistics, research and development, bioinformatics, and clinical pharmacometrics at Certara, AstraZeneca, Metamark Genetics, Novartis, and MITRE.
- Served as a tenured Associate Professor in the Department of Mathematics and Statistics at Texas Tech.
- Holds multiple degrees, including a B.S. from Virginia Tech, an M.S. in Engineering Mechanics from Virginia Polytechnic Institute, a Ph.D. in Applied Mathematics/Probability Theory from University of Maryland, an M.S. in Biostatistics from the Harvard T.H. Chan School of Public Health, and an M.S. in Regulatory Affairs from Northeastern University.
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information